Research progress in the prevention of contrast-related acute kidney injury

VernacularTitle:预防对比剂相关性急性肾损伤的研究进展
Author: Hui FAN ¹ ; Yu MA ; Ximing LI
Author Information

1. 天津医科大学(邮编 300070)
Keywords: contrast media; acute kidney injury; hydroxymethylglutaryl-CoA reductase inhibitors; nanoparticles; fluid therapy
From: Tianjin Medical Journal 2024;52(3):327-331
CountryChina
Language:Chinese
Abstract: Contrast-associated acute kidney injury(CA-AKI)is an important complication caused by the use of contrast medium(CM)in diagnostic or interventional surgery.At present,it has become one of the major causes of acute renal insufficiency in hospitalized patients.Choosing a relatively low toxic CM and reducing the exposure time and dose of CM can prevent CA-AKI occurrence to some extent.Drugs such as statins and postoperative hydration can reduce the risk of CA-AKI.In addition,nanomedicine has shown a benefit in animal models.This paper reviews the current prevention and treatment of CA-AKI to lay the foundation for further study of new interventions and provide a theoretical basis for clinical treatment.